Literature DB >> 12846371

Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhône-Alpes region of France.

Hervé Besson1, Philippe Renaudier, Ray M Merrill, Bertrand Coiffier, Catherine Sebban, Jacques Fabry, Christian Trepo, Annie J Sasco.   

Abstract

OBJECTIVE: To study the relation between smoking and non-Hodgkin's lymphoma (NHL), in the Rhône-Alpes region of France.
METHODS: We conducted a hospital-based case-control study that included 180 cases of NHL and 360 age-, gender-matched hospital controls. Matched univariable and multivariable logistic regression models were used for analysis.
RESULTS: For the whole study population as well as for men, smoking does not elevate the risk of NHL. However, the risk of NHL is higher for women who currently smoke compared to women who have never smoked (odds ratio [OR] = 2.40, 95% confidence interval [95% CI] = 1.19-4.84). Among ever smokers, the OR of NHL is 5.04 (95% CI = 1.40-18.12) for women who have smoked for more than 30 years compared with those who have never smoked. Similarly, women who started to smoke before the age of 20 years compared with women who have never smoked are at greater risk of developing NHL (OR = 2.40, 95% CI = 0.99-5.85). In the total population (women and men), smoking may be associated with one histologic subtype, follicular NHL with an adjusted OR for the current smokers compared to subjects having never smoked of 3.20, 95% CI = 0.79-12.97.
CONCLUSIONS: In spite of the small number of subjects in the subgroups, a relation is observed between smoking and NHL among women, but not men, and in the total population a relation is suggested between smoking and follicular NHL.

Entities:  

Mesh:

Year:  2003        PMID: 12846371     DOI: 10.1023/a:1023978730962

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Risks and benefits of azathioprine therapy.

Authors:  D P B McGovern; D P Jewell
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

2.  Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.

Authors:  Lenka Goldman; Sameera Ezzat; Nadia Mokhtar; Amany Abdel-Hamid; Nathan Fowler; Iman Gouda; Soheir Abdel Latif Eissa; Mohamed Abdel-Hamid; Christopher A Loffredo
Journal:  Cancer Causes Control       Date:  2009-03-05       Impact factor: 2.506

3.  Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study.

Authors:  Yani Lu; Sophia S Wang; Peggy Reynolds; Ellen T Chang; Huiyan Ma; Jane Sullivan-Halley; Christina A Clarke; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2011-07-18       Impact factor: 4.897

4.  Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia.

Authors:  Michael K Odutola; Marina T van Leeuwen; Jennifer Turner; Fiona Bruinsma; John F Seymour; Henry M Prince; Samuel T Milliken; Judith Trotman; Emma Verner; Campbell Tiley; Fernando Roncolato; Craig R Underhill; Stephen S Opat; Michael Harvey; Mark Hertzberg; Geza Benke; Graham G Giles; Claire M Vajdic
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

5.  Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.

Authors:  Briseis A Kilfoy; Tongzhang Zheng; Qing Lan; Xuesong Han; Theodore Holford; David W Hein; Qin Qin; Brian Leaderer; Lindsay M Morton; Meredith Yeager; Peter Boyle; Ping Zhao; Stephen Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2009-10-07       Impact factor: 2.506

6.  Family and social predictors of substance use disorder in Iran: a case-control study.

Authors:  Gholamhossein Shahraki; Zahra Sedaghat; Mohammad Fararouei
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-05-06

7.  Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women.

Authors:  L M Morton; T R Holford; B Leaderer; P Boyle; S H Zahm; Y Zhang; S Flynn; G Tallini; B Zhang; P H Owens; T Zheng
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.